GFM
MIRM icon

GF Fund Management’s Mirum Pharmaceuticals MIRM Stock Holding History

GF Fund Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Buy
1,280
+125
+11% +$12.6K ﹤0.01% 297
2026
Q1 		$107K Buy
1,155
+147
+15% +$13.8K ﹤0.01% 334
2025
Q4 		$79.6K Sell
1,008
-73
-7% -$5.24K ﹤0.01% 364
2025
Q3 		$79.2K Sell
1,081
-147
-12% -$9.35K ﹤0.01% 352
2025
Q2 		$62.5K Hold
1,228
– – ﹤0.01% 395
2025
Q1 		$55.3K Buy
1,228
+220
+22% +$10.4K ﹤0.01% 409
2024
Q4 		$41.7K Buy
+1,008
New +$42K ﹤0.01% 406

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GF Fund Management's MIRM Position: Q2 2026 in Review

GF Fund Management increased its Mirum Pharmaceuticals (MIRM) stake by 11% in Q2 2026, buying an estimated $12.6K and bringing the position to 1,280 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #297.

GF Fund Management first reported a position in MIRM in Q4 2024 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • GF Fund Management held 1,280 shares of Mirum Pharmaceuticals worth $150K as of Q2 2026.
  • GF Fund Management bought 125 Mirum Pharmaceuticals shares in Q2 2026, an estimated $12.6K.
  • Mirum Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #297 holding.
  • GF Fund Management first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.